Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients

Phase 4 Terminated 28 enrolled Emory University National Institute of General Medical Sciences (NIGMS) · collab

RandomizedParallel-groupOpen-labelTreatment

Summary

This study is a prospective randomized study to examine the effects of exposure to dulaglutide on the prevention of stress-hyperglycemia and the metabolic inflammatory response in the perioperative period.

Timeline

Start: 2019-03-08
Primary completion: 2023-05-02
Completion: 2023-05-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Dulaglutide	Peptide	0.75 mg	—

Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients

Summary

Timeline

Drugs

Indications